📰 Applied Life Sciences News
Applied Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Applied Life Sciences. Real-time updates on events, politics, business and more.
May 2, 2024
Could a personalized thermostat be a game-changing menopause device or hot-sleeping hack?
March 25, 2024
In a boon for medical researchers, new tool is the first that can measure both mechanical movement and electrical signal in vitro using a single sensor
March 11, 2024
Research provides new insights into how cells in plants coordinate their responses. A team of researchers from the University of Massachusetts Amherst recently published a pioneering study that answers a central question in biology: how do organisms rally a wide range of cellular processes when the
February 7, 2024
UMass Amherst team uncovers plant cellular process responses to environmental changes.
December 24, 2023
Team develops test to identify new drugs that can disable pathogens and so make real gains in public health. Antibiotic-resistant “superbugs” that can defeat efforts to kill them are an urgent public health crisis, and according to the CDC, more than 2.8 million antibiotic-resistant infections oc
December 22, 2023
Antibiotic-resistant “superbugs” that can defeat efforts to kill them are an urgent public health crisis, and according to the CDC, more than 2.8 million antibiotic-resistant infections occur each year. Researchers across the world are scrambling to
December 19, 2023
Antibiotic-resistant "superbugs" that can defeat efforts to kill them are an urgent public health crisis, and according to the Centers for Disease Control, more than 2.8 million antibiotic-resistant infections occur each year.
December 4, 2023
Xheme, a specialty materials company affiliated with the UMass Innovation Institute, has developed a non-toxic programmable powder that can be customized based on application and boast a range of promising uses.
November 2, 2023
SEATTLE, November 02, 2023--ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate (ADC) therapeutics for cancer, today announced the addition of multiple industry veterans to its leadership team to support its growth.